Filing Flows › Cerenome (CNSY) › Recalls, complaints & regulation
Cerenome (CNSY): clinical trials
Cerenome (CNSY) beyond its filings: 4 active clinical trials.
Cerenome's latest quarter
Cerenome, Q2 2026: revenue $411K (-70% year over year), net loss $9.0M, operating cash flow −$7.1M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Cerenome have?
4 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.